127 related articles for article (PubMed ID: 5379868)
1. B 663 (Lampren) in mycobacterial infections.
Pettit JH
Br J Dermatol; 1969 Oct; 81(10):794-5. PubMed ID: 5379868
[No Abstract] [Full Text] [Related]
2. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.
Pettit JH; Rees RJ; Ridley DS
Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368
[No Abstract] [Full Text] [Related]
3. B.663 (Geigy 30. 320) in the treatment of leprosy. A preliminary report.
Devadason C
Acta Trop; 1969; 26(3):265-9. PubMed ID: 4391239
[No Abstract] [Full Text] [Related]
4. [Activity of B663 in lepromatous leprosy. Therapeutic trial].
Pene P; Carrie J; Bourgeade A; Bolliot Y
Bull Soc Pathol Exot Filiales; 1971; 64(4):407-15. PubMed ID: 5172361
[No Abstract] [Full Text] [Related]
5. G 30 320 or B 663--lampren (Geigy).
Waters MF
Lepr Rev; 1969 Jan; 40(1):21-47. PubMed ID: 4888382
[No Abstract] [Full Text] [Related]
6. Correlation of laboratory and clinical data during treatment of leprosy.
Pattyn SR; Rollier R; Rollier MR; De Muynck A; Janssens PG; Verdoolaeghe-Van Loo G
Ann Soc Belg Med Trop; 1972; 52(6):537-48. PubMed ID: 4574223
[No Abstract] [Full Text] [Related]
7. Effect of B.1912, a new riminophenazine derivative in murine leprosy.
Chang YT
Int J Lepr Other Mycobact Dis; 1970; 38(4):417-21. PubMed ID: 5534494
[No Abstract] [Full Text] [Related]
8. A study of skin pigmentation by clofazimine.
Levy L; Randall HP
Int J Lepr Other Mycobact Dis; 1970; 38(4):404-16. PubMed ID: 5534493
[No Abstract] [Full Text] [Related]
9. Double-blind controlled clinical trial of clofazimine in reactive phases of lepromatous leprosy.
Karat AB; Jeevaratnam A; Karat S; Rao PS
Br Med J; 1970 Jan; 1(5690):198-200. PubMed ID: 4904935
[TBL] [Abstract][Full Text] [Related]
10. [Mycobacterium ulcerans infection in man (Baruli-ulcer)].
Kieninger G; Schubert GE; Ullmann U; Höfler W
Infection; 1973; 1(1):46-53. PubMed ID: 4594782
[No Abstract] [Full Text] [Related]
11. [Lampren in the treatment of leprosy].
Ahrens T
Schweiz Rundsch Med Prax; 1970 Mar; 59(11):387-9. PubMed ID: 5519711
[No Abstract] [Full Text] [Related]
12. Treatment of leprosy with Lampren (B.663 Geigy).
De las Aguas JT
Int J Lepr Other Mycobact Dis; 1971; 39(2):493-503. PubMed ID: 4948089
[No Abstract] [Full Text] [Related]
13. [Action of B663 on obstinate reactogenic forms of Hansen's disease].
Rostant MM
Bord Med; 1970 Apr; 3(4):1033-4 passim. PubMed ID: 5422391
[No Abstract] [Full Text] [Related]
14. Histochemistry of B663 pigmentation: ceroid-like pigmentation in macrophages.
Sakurai I; Skinsnes OK
Int J Lepr Other Mycobact Dis; 1977; 45(4):343-54. PubMed ID: 75860
[TBL] [Abstract][Full Text] [Related]
15. A new analogous model for the detection and evaluation of chemotherapeutic products effective in leprosy.
Freerksen E; Rosenfeld M
Arzneimittelforschung; 1972 Aug; 22(8):1235-42. PubMed ID: 4678384
[No Abstract] [Full Text] [Related]
16. Lipids in leprosy. 2. Histochemistry of lipids in human leprosy.
Sakurai I; Skinsnes OK
Int J Lepr Other Mycobact Dis; 1970; 38(4):389-403. PubMed ID: 4102020
[No Abstract] [Full Text] [Related]
17. Evaluation of B.663 in human leprosy.
Atkinson AJ; Sheagren JN; Rubio JB; Knight V
Int J Lepr Other Mycobact Dis; 1967; 35(2):119-27. PubMed ID: 5338956
[No Abstract] [Full Text] [Related]
18. Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report.
Tolentino JG; Rodriquez JN; Abalos RM
Int J Lepr Other Mycobact Dis; 1971; 39(3):738-41. PubMed ID: 5169924
[No Abstract] [Full Text] [Related]
19. Drugs for leprosy.
Rees RJ
Trop Doct; 1973 Apr; 3(2):92-5. PubMed ID: 4691437
[No Abstract] [Full Text] [Related]
20. Lamprene: first results of treatment in the Netherlands in a group of 6 leprosy patients.
Hogerzeil LM
Dermatologica; 1971; 143(6):339-44. PubMed ID: 5150817
[No Abstract] [Full Text] [Related]
[Next] [New Search]
